Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 80
Selected: 0
NCT IDTitle
NCT05998304ADME Study of [14C] Yiqibuvir in Healthy Male Subjects
NCT04194242The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects
NCT03888092Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
NCT05127772A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing
NCT04623814the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT04232514Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
NCT03092102The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
NCT07376200Single-ascending Dose Study of HEC-151 Injection
NCT05060822Phase ll Study of HEC585 in Patients With IPF
NCT05492630Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects
NCT05586074HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT04984512The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT03502902The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT04667429the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
NCT05504876Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NCT05059743ADME Study of [14C]- Larotinib in Healthy Male Subjects
NCT07211165Clinical Study on the Mass Balance of Clifutinib
NCT03903081The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects
NCT05383131To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
NCT04324372Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
NCT05576298A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects
NCT03673696The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
NCT07082842Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT07341672A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT05446233ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects
NCT04591301The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
NCT04147208Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
NCT07102251A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
NCT04865458A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
NCT04201275The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
NCT04925674Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
NCT04982913Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
NCT05057949A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
NCT05397379A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis
NCT04601610KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
NCT05133882A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
NCT07099118A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
NCT03663686The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
NCT05454098Clifutinib Food Effect Study in Healthy Subjects
NCT04565171Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD
NCT03811678The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
NCT04551261GLS4/RTV and TAF Drug-drug Interaction
NCT04422496The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
NCT03662568A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
NCT04512170Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects